These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 21623040)

  • 21. Mechanisms of fluoroquinolone monoresistance in Mycobacterium tuberculosis.
    Lu J; Liu M; Wang Y; Pang Y; Zhao Z
    FEMS Microbiol Lett; 2014 Apr; 353(1):40-8. PubMed ID: 24822277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular detection of drug resistance to ofloxacin and kanamycin in Mycobacterium tuberculosis by using multiplex allele-specific PCR.
    Kumari R; Banerjee T; Anupurba S
    J Infect Public Health; 2018; 11(1):54-58. PubMed ID: 28404233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. gyrA mutations and phenotypic susceptibility levels to ofloxacin and moxifloxacin in clinical isolates of Mycobacterium tuberculosis.
    Sirgel FA; Warren RM; Streicher EM; Victor TC; van Helden PD; Böttger EC
    J Antimicrob Chemother; 2012 May; 67(5):1088-93. PubMed ID: 22357804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular detection of fluoroquinolone resistance-associated gyrA mutations in ofloxacin-resistant clinical isolates of Mycobacterium tuberculosis from Iran and Belarus.
    Arjomandzadegan M; Titov L; Farnia P; Owlia P; Ranjbar R; Sheikholeslami F; Surkova L
    Int J Mycobacteriol; 2016 Sep; 5(3):299-305. PubMed ID: 27847014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of efflux pump inhibitors on the susceptibility of
    Jaiswal I; Jain A; Verma SK; Singh P; Kant S; Singh M
    Lung India; 2017; 34(6):499-505. PubMed ID: 29098993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular characteristics of ofloxacin mono-resistant Mycobacterium tuberculosis isolates from new and previously treated tuberculosis patients.
    Wang Z; Xie T; Mu C; Wang C; Ju H; Zhao H; Sun R
    J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28317169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of pyrazinamide and ofloxacin resistance among drug resistant Mycobacterium tuberculosis isolates from Singapore.
    Lee AS; Tang LL; Lim IH; Wong SY
    Int J Infect Dis; 2002 Mar; 6(1):48-51. PubMed ID: 12044302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of DNA Gyrase Activity and Elucidation of the Impact of Amino Acid Substitution in GyrA on Fluoroquinolone Resistance in Mycobacterium avium.
    Thapa J; Chizimu JY; Kitamura S; Akapelwa ML; Suwanthada P; Miura N; Toyting J; Nishimura T; Hasegawa N; Nishiuchi Y; Gordon SV; Nakajima C; Suzuki Y
    Microbiol Spectr; 2023 Jun; 11(3):e0508822. PubMed ID: 37067420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA expression analysis of efflux pump genes in clinical isolates of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in South Korea.
    Oh TS; Kim YJ; Kang HY; Kim CK; Cho SY; Lee HJ
    Infect Genet Evol; 2017 Apr; 49():111-115. PubMed ID: 28062386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the Diagnostic Performance of MeltPro and Next-Generation Sequencing in Determining Fluoroquinolone Resistance in Multidrug-Resistant Tuberculosis Isolates.
    Hu Y; Chi Y; Feng X; Yu F; Li H; Shang Y; Pan J; Pang Y
    J Mol Diagn; 2023 Jun; 25(6):342-351. PubMed ID: 37208048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mycobacterium tuberculosis Gene Expression Associated With Fluoroquinolone Resistance and Efflux Pump Inhibition.
    van der Heijden YF; Maruri F; Blackman A; Morrison R; Guo Y; Sterling TR
    J Infect Dis; 2023 Aug; 228(4):469-478. PubMed ID: 37079382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extending the definition of the GyrB quinolone resistance-determining region in Mycobacterium tuberculosis DNA gyrase for assessing fluoroquinolone resistance in M. tuberculosis.
    Pantel A; Petrella S; Veziris N; Brossier F; Bastian S; Jarlier V; Mayer C; Aubry A
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1990-6. PubMed ID: 22290942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlating Minimum Inhibitory Concentrations of ofloxacin and moxifloxacin with gyrA mutations using the genotype MTBDRsl assay.
    Kambli P; Ajbani K; Sadani M; Nikam C; Shetty A; Udwadia Z; Rodwell TC; Catanzaro A; Rodrigues C
    Tuberculosis (Edinb); 2015 Mar; 95(2):137-41. PubMed ID: 25522842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of gyrA gene mutations between laboratory-selected ofloxacin-resistant Mycobacterium tuberculosis strains and clinical isolates.
    Sun Z; Zhang J; Zhang X; Wang S; Zhang Y; Li C
    Int J Antimicrob Agents; 2008 Feb; 31(2):115-21. PubMed ID: 18164184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibility testing breakpoints for Mycobacterium tuberculosis categorize isolates with resistance mutations in gyrA as susceptible to fluoroquinolones: implications for MDR-TB treatment and the definition of XDR-TB.
    Niward K; Ängeby K; Chryssanthou E; Paues J; Bruchfeld J; Jureen P; Giske CG; Kahlmeter G; Schön T
    J Antimicrob Chemother; 2016 Feb; 71(2):333-8. PubMed ID: 26538509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra.
    Kocagöz T; Hackbarth CJ; Unsal I; Rosenberg EY; Nikaido H; Chambers HF
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1768-74. PubMed ID: 8843279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. gyrA and gyrB mutations in ofloxacin-resistant Mycobacterium tuberculosis clinical isolates in Thailand.
    Pitaksajjakul P; Worakhunpiset S; Chaiprasert A; Boonyasopun J; Ramasoota P
    Southeast Asian J Trop Med Public Health; 2011 Sep; 42(5):1163-7. PubMed ID: 22299442
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Tudó G; Lopez-Gavin A; Portell-Buj E; Freixes J; Vila J; Roman A; Monté MR; Gonzalez-Martin J
    Microb Drug Resist; 2020 Sep; 26(9):1019-1022. PubMed ID: 32159449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of four efflux pump inhibitors on the activities of clarithromycin against
    Teng TL; Shang YY; Huang HR; Chu NH; Chen ST
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 May; 45(5):468-474. PubMed ID: 35527462
    [No Abstract]   [Full Text] [Related]  

  • 40. Characterization of gyrA and gyrB mutations and fluoroquinolone resistance in Mycobacterium tuberculosis clinical isolates from Hubei Province, China.
    Chen J; Chen Z; Li Y; Xia W; Chen X; Chen T; Zhou L; Xu B; Xu S
    Braz J Infect Dis; 2012; 16(2):136-41. PubMed ID: 22552454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.